UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
NOAC race: Pradaxa prescription numbers fall behind fast followers
by Marian Chu
2017-09-14 19:02
Opdivo vs. Keytruda - which will doctors choose?
by Marian Chu
2017-09-14 17:54
AstraZeneca regains momentum with positive Imfinzi results
by Marian Chu
2017-09-14 13:34
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea
by Marian Chu
2017-09-13 18:33
Alvogen Korea to sell Vivus’ obesity drug
by Marian Chu
2017-09-13 18:16
라인
Opdivo’s expanded indications ease cancer patients’ worries
by Marian Chu
2017-09-13 16:57
EU approves Abbvie’s Humira as first biologic to treat CHMP
by Marian Chu
2017-09-12 15:45
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share
by Marian Chu
2017-09-12 13:26
Abbvie lands 1st place on Dow Jones Sustainability Index
by Marian Chu
2017-09-11 14:38
GSK’s HIV drug ranked No. 1 in Q2 sales
by Marian Chu
2017-09-11 14:37
라인
FDA orders halt on Opidvo trials
by Marian Chu
2017-09-08 16:39
Give peanut butter to infants to prevent peanut allergy: study
by Marian Chu
2017-09-08 11:42
EU grants 1st approval for Siemens' new MRI scanner
by Marian Chu
2017-09-07 16:38
Teva-Handok wins approval for anti-asthma injection
by Marian Chu
2017-09-07 14:58
Novartis Korea gains approval for skin disease biologic
by Marian Chu
2017-09-07 14:28
라인
BMS, Pfizer prove safety for blood-thinning drug in P4 trial
by Marian Chu
2017-09-06 17:40
Novartis’ Revolade proved effective for seniors
by Marian Chu
2017-09-06 12:53
Will Amgen’s Repatha succeed in the Korean market?
by Marian Chu
2017-09-06 09:07
Pfizer Korea releases new tool for rheumatism injection
by Marian Chu
2017-09-05 17:22
Celgene Korea names new CEO
by Marian Chu
2017-09-05 14:22
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top